Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6 polymorphisms and hematologic malignancy: a re-appraisal of evidence from genetic association studies.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals - 1 Nov 2013

Ziakas Panayiotis D, Karsaliakos Petros, Prodromou Michael L, Mylonakis Eleftherios

Abstract excerpt

CONTEXT: Interleukin-6 (IL-6) is implicated in the pathophysiology of hematologic neoplasia. OBJECTIVE: To review the role of IL-6 single nucleotide polymorphisms (SNPs) in hematologic neoplasia. METHODS: PubMed and EMBASE search of genetic association studies. Effects were summarized using the model-free generalized odds ratio (ORG), and the mode of inheritance was estimated for significant associations....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-6

Share to Lymphoma

Share to Multiple Myeloma

Share to Polymorphism, Single Nucleotide

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 24059848
DOI: 10.3109/1354750X.2013.840799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6 polymorphisms and hematologic malignancy: a re-appraisal of evidence from genetic association studies.PMID 24059848Read ↗

Genetic variation in IL-6 rs1800796 and its association with non-Hodgkin lymphoma susceptibility in the Egyptian populationSemantic proximity Read ↗

Association of IL-6 Promoter and Receptor Polymorphisms with Multiple Myeloma Risk: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls.Semantic proximity Read ↗

Interleukin-6 gene-174 G/C promoter polymorphism is not associated with multiple myeloma susceptibility: evidence from meta-analysis: A systematic review and meta-analysis.Semantic proximity Read ↗

Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk.Semantic proximity Read ↗

Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.Semantic proximity Read ↗

Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma.Semantic proximity Read ↗

The genetic polymorphisms of immune-related genes contribute to the susceptibility and survival of lymphoma.Semantic proximity Read ↗

Analysis of Interleukin-6 Gene Variants (rs1800795, rs1800796, rs1554606, rs1800797, rs2069840, rs12700386, and rs2069861) as Prognostic Markers in Breast Cancer: A Systematic Review, Meta-Analysis, and Network Analysis.Semantic proximity Read ↗

Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).Semantic proximity Read ↗

Interleukin-6 as a Pan-Cancer Prognostic Inflammatory Biomarker: A Population-Based Study and Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.